+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Point of Care & Rapid Diagnostics Market by Platform, Sample, Purchase, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715637
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Point of Care & Rapid Diagnostics Market grew from USD 48.43 billion in 2023 to USD 51.85 billion in 2024. It is expected to continue growing at a CAGR of 7.11%, reaching USD 78.34 billion by 2030.

The Point of Care (POC) and Rapid Diagnostics market is centered around medical testing that is conducted near the site of patient care, offering quick and efficient diagnosis. This market is essential as it facilitates timely medical decisions, particularly vital in regions with limited access to traditional healthcare facilities. Applications range from blood glucose testing, pregnancy tests, and infectious disease detection to cholesterol and cardiac markers monitoring. The end-use sectors primarily include hospitals, diagnostic centers, home care settings, and research laboratories. Key growth influencers comprise the ongoing advances in technology that enhance test accuracy and reduce costs, the growing prevalence of infectious diseases, and the increased demand for home healthcare solutions. Opportunities lie in expanding digital connectivity to integrate rapid diagnostics with telehealth services, offering real-time monitoring and data sharing capabilities. Challenges include regulatory compliance issues, the need for substantial investment in Research & Development, and competition from established laboratory diagnostics. Limitations also stem from inconsistent reimbursement policies across regions and variability in test reliability and accuracy. Innovating in wearable and smartphone-based diagnostics, enhancing point-of-care diagnostics for chronic disease management, and expanding AI integration for predictive healthcare can significantly propel the market forward. Analysis of consumer preferences and feedback will guide innovation, ensuring the development of user-friendly and cost-effective solutions. As the market is characterized by rapid technological shifts and significant academic-industrial collaboration, maintaining a competitive edge is paramount. Businesses should invest in robust R&D and strategic partnerships to enhance market presence and adapt to evolving healthcare demands. Identifying untapped markets, particularly in emerging economies, and focusing on regulatory compliance will provide avenues for continual growth and expansion within this dynamic field.

Understanding Market Dynamics in the Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • High oprevelance of the infectious diseases
    • Proliferation of decentralized healthcare systems
    • Supportive government policies
  • Market Restraints
    • Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
  • Market Opportunities
    • Innovative POC test with multiplexing capabilities
  • Market Challenges
    • Alternate effective ways of diagnosis in laboratories

Exploring Porter’s Five Forces for the Point of Care & Rapid Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Point of Care & Rapid Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Point of Care & Rapid Diagnostics Market

External macro-environmental factors deeply influence the performance of the Point of Care & Rapid Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Point of Care & Rapid Diagnostics Market

The Point of Care & Rapid Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Point of Care & Rapid Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, inc., bioMérieux SA, Cardinal Health, Inc., Co-Diagnostics, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Genomadix Inc., Lucira Health, Inc., Meridian Bioscience Inc. by SD Biosensor, Novartis AG, OraSure Technologies, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Point of Care & Rapid Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Platform
    • Dipstick
    • Immunoassay
    • Microfluidics
  • Sample
    • Blood
    • Urine
  • Purchase
    • OTC
    • Prescription
  • End-User
    • Homecare
    • Hospital
    • Pharmacy
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Point of Care & Rapid Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High oprevelance of the infectious diseases
5.1.1.2. Proliferation of decentralized healthcare systems
5.1.1.3. Supportive government policies
5.1.2. Restraints
5.1.2.1. Reduced awareness of new rapid diagnostic tests and lack of standard regulatory methods
5.1.3. Opportunities
5.1.3.1. Innovative POC test with multiplexing capabilities
5.1.4. Challenges
5.1.4.1. Alternate effective ways of diagnosis in laboratories
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Point of Care & Rapid Diagnostics Market, by Platform
6.1. Introduction
6.2. Dipstick
6.3. Immunoassay
6.4. Microfluidics
7. Point of Care & Rapid Diagnostics Market, by Sample
7.1. Introduction
7.2. Blood
7.3. Urine
8. Point of Care & Rapid Diagnostics Market, by Purchase
8.1. Introduction
8.2. OTC
8.3. Prescription
9. Point of Care & Rapid Diagnostics Market, by End-User
9.1. Introduction
9.2. Homecare
9.3. Hospital
9.4. Pharmacy
10. Americas Point of Care & Rapid Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Point of Care & Rapid Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Point of Care & Rapid Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Becton, Dickinson and Company
14.1.3. Binx Health, inc.
14.1.4. bioMérieux SA
14.1.5. Cardinal Health, Inc.
14.1.6. Co-Diagnostics, Inc.
14.1.7. Danaher Corporation
14.1.8. F. Hoffmann-La Roche AG
14.1.9. Genomadix Inc.
14.1.10. Lucira Health, Inc.
14.1.11. Meridian Bioscience Inc. by SD Biosensor
14.1.12. Novartis AG
14.1.13. OraSure Technologies, Inc.
14.1.14. Siemens Healthineers AG
14.1.15. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2030 (%)
FIGURE 8. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
FIGURE 10. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2030 (%)
FIGURE 12. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 6. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIPSTICK, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 10. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 13. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 33. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 34. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 35. CANADA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 37. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 55. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 56. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 57. CHINA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 59. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 60. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 61. INDIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 67. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 91. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 93. THAILAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 104. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 106. DENMARK POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 108. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 110. EGYPT POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 112. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 114. FINLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 116. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 118. FRANCE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 120. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 128. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 129. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 130. ITALY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 140. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 144. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 145. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 146. POLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 148. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 149. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 150. QATAR POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 164. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 166. SPAIN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 176. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PURCHASE, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 188. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 189. POINT OF CARE & RAPID DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Point of Care & Rapid Diagnostics Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Binx Health, inc.
  • bioMérieux SA
  • Cardinal Health, Inc.
  • Co-Diagnostics, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Genomadix Inc.
  • Lucira Health, Inc.
  • Meridian Bioscience Inc. by SD Biosensor
  • Novartis AG
  • OraSure Technologies, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information